Your browser doesn't support javascript.
loading
Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease.
Aschenbrenner, Andrew J; Baksh, R Asaad; Benejam, Bessy; Beresford-Webb, Jessica A; Coppus, Antonia; Fortea, Juan; Handen, Benjamin L; Hartley, Sigan; Head, Elizabeth; Jaeger, Judith; Levin, Johannes; Loosli, Sandra V; Rebillat, Anne-Sophie; Sacco, Silvia; Schmitt, Frederick A; Thurlow, Kate E; Zaman, Shahid; Hassenstab, Jason; Strydom, Andre.
Afiliación
  • Aschenbrenner AJ; Washington University in St. Louis, Department of Neurology St. Louis Missouri USA.
  • Baksh RA; Institute of Psychiatry, Psychology, and Neuroscience Department of Forensic and Neurodevelopmental Sciences King's College London London UK.
  • Benejam B; The London Down Syndrome (LonDownS) Consortium London UK.
  • Beresford-Webb JA; Barcelona Down Medical Center Fundació Catalana Síndrome de Down Barcelona Spain.
  • Coppus A; Cambridge Intellectual and Developmental Disabilities Research Group Department of Psychiatry University of Cambridge Cambridge UK.
  • Fortea J; Department of Primary and Community Care Radboud University Medical Center Nijmegen The Netherlands.
  • Handen BL; Barcelona Down Medical Center Fundació Catalana Síndrome de Down Barcelona Spain.
  • Hartley S; Memory Unit and Biomedical Research Institute Sant Pau (IIB Sant Pau) Neurology Department Hospital de la Santa Creu i Sant Pau Barcelona Spain.
  • Head E; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED) Madrid Spain.
  • Jaeger J; Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA.
  • Levin J; Department of Human Development & Family Studies University of Wisconsin-Madison Madison Wisconsin USA.
  • Loosli SV; Department of Pathology & Laboratory Medicine University of California Irvine California USA.
  • Rebillat AS; CognitionMetrics LLC. Wilmington Delaware USA.
  • Sacco S; Deptment of Psychiatry and Behavioral Sciences Albert Einstein College of Medicine Bronx New York USA.
  • Schmitt FA; Department of Neurology Ludwig-Maximilians-Universität München Munich Germany.
  • Thurlow KE; German Center for Neurodegenerative Diseases Munich Germany.
  • Zaman S; Munich Cluster for Systems Neurology (SyNergy) Munich Germany.
  • Hassenstab J; Department of Neurology Ludwig-Maximilians-Universität München Munich Germany.
  • Strydom A; Jerome Lejeune Institute Paris France.
Alzheimers Dement (Amst) ; 13(1): e12184, 2021.
Article en En | MEDLINE | ID: mdl-33969175
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Dement (Amst) Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Dement (Amst) Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos